entertainment -WSS

entertainment

author：comprehensive 2025-09-28 23:30:01 - browse：79178

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： STAT Readout: Today's biotech news includes Sana and Amylyx

hotspot

WSS

Medicare to cover more brain scans related to Alzheimer’s drugs

Data integrity in scientific journals requires "effort" by publishers, institutions

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Solving academic medical centers' existential crisis

A revolution in caring for preterm infants

Cytokinetics CEO stresses company can launch heart drug on its own

hotspot

entertainment

explore

The cancer drug shortage isn’t new — and neither are the solutions

What the Wegovy shortage looks like for doctors — and for patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

European regulators recommend Amylyx's ALS drug be rejected

Activists slam private health insurers over coverage restrictions

What's changing in Medicare's open enrollment this year?

Activists slam private health insurers over coverage restrictions

Venture capitalist Bob Kocher on the state of digital health

United colonoscopy coverage change 'may cost lives,' doctors say

Military medical care influenced by rank and race, new study finds

entertainment

Addiction experts warn against a second 'war on drugs'

HIV vaccine remains elusive. Immunologists keep trying new ideas

European regulators recommend Amylyx's ALS drug be rejected

Cancer cells are shown to suck energy source from immune cells

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Helping hospitals and community health centers plan for resilience

hotspot

hotspot

Wikipedia

Wikipedia